Amtelip Tablets
Clinical Summary
Quick overview from the medicine insert
Indication
Management of hypertension and reduction of cardiovascular risk in patients with hypertension and additional risk factors.
Dosage (summary)
The usual starting dose is 40mg/5mg or 80mg/5mg once daily. The dose may be adjusted based on blood pressure response.
Onset of Action / Duration
Antihypertensive effects can be observed within 2 weeks of initiation, with maximum effect typically seen after 4-6 weeks.
Special Populations
- Elderly patients may require dose adjustment.
- Patients with renal impairment should be monitored closely.
- Patients with hepatic impairment may require dose adjustment.
Pregnancy & Breastfeeding
Use during pregnancy is not recommended. It is not known if Amlodipine or Telmisartan is excreted in human milk; caution should be exercised when administering to nursing mothers.
Key Drug Interactions
- Caution with concomitant use of other antihypertensive agents.
- Avoid use with potassium-sparing diuretics or potassium supplements.
- Caution with NSAIDs as they may reduce the antihypertensive effect.
Contraindications
- Hypersensitivity to Amlodipine, Telmisartan, or any component of the formulation.
- Severe hepatic impairment.
- Pregnancy.
Common side effects
- Dizziness
- Fatigue
- Headache
- Peripheral edema
- Hypotension
Counselling Points
- Advise patients to take the medication at the same time each day.
- Instruct patients to report any signs of hypotension or persistent cough.
- Encourage lifestyle modifications such as diet and exercise to enhance blood pressure control.
Serious warnings
- Monitor renal function periodically during treatment.
- Use with caution in patients with a history of angioedema.
- Discontinue if signs of liver dysfunction occur.
Important Disclaimer
The Amtelip Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
